Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Score changes after a secured card usually appear over weeks to months, driven by utilization and payment history. Here’s how to gauge progress.
25,781 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Texas and Charlotte builders are moving away from sprawling McMansions, adopting California-inspired design cues to d...
Two consumer-facing stocks sit at a crossroads: GameStop is tightening its turnaround with a leaner footprint, while ...
Microsoft’s stock has fallen out of step with broader AI enthusiasm as Copilot results lag and cloud growth cools, le...
Two industrial names sit at the center of the rare-earth supply story: MP Materials and TMC The Metals Company. This ...
Broadcom just unveiled a chip aimed at speeding AI inference. Could this chip game shift the trajectory for AVGO stoc...
PTIR's double-leveraged bet on Palantir underperformed the stock by nearly half over the past year, underscoring the ...
Could Energy Transfer (ET) outpace the broad market in the second half of 2026? This article builds a practical, data...
Meta Platforms is signaling a bold pivot toward AI-focused cloud capacity. This article breaks down what neocloud wou...
The SK Hynix IPO set a new milestone, underscoring soaring demand for AI memory. This article breaks down what hynix ...
Velocity closes a $38 million Series A to scale stablecoin-enabled payments for cross-border settlements, backed by a...
A nationwide surge in AI use for homework collides with a growing gap in school policies. This report tracks the numb...